Volume 111, Issue 1 supplement

Search all Journal of Cancer Research and Clinical Oncology articles

February 1986

Filter by

Volume:

Sort by

Date published:

New to old Old to new

608 articles in this issue

Physical and radiobiological basis of the combination of interstitial and percutaneous radiotherapy
R. G. Müller
H. -J. Thiel
R. Sauer
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S13 - S13
First experiences in brachy-curietherapy of head and neck tumors with 125 J-seeds in carrier and 192 Ir-afterloading system
W. Schwab
G. Ries
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S13 - S13
Head and neck cancer — treatment by permanent and/or removable interstitial radioactive implants
R. Don Goffinet
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S14 - S14
Clinical experience with iodine-125-seeds in locally advanced tumors of the GI-tract
J. R. Siewert
O. H. Bertermann
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S14 - S14
Treatment of soft tissue sarcoma of limbs by function-saving resection and brachytherapy
M. H. Shiu
B. S. Hilaris
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S14 - S14
The palliatve high dose rate afterloading therapy in combination with endoscopic laser treatment of malign stenoses of the upper gastrointestinal tract
M. Bader
H. J. Dittler
J. R. Siewert
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S14 - S14
High dose-rate afterloading radiation therapy for the treatment of bile duct carcinomas
G. Ries
F. Hagenmüller
P. Kneschaurek
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S15 - S15
Clinical results of afterloading short-term therapy compared with radium therapy
K. Rotte
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S15 - S15
High-dose-rate (HDR)-192 IR-afterloading irradiation of the prostatic carcinoma
H. Lindner
P. Kneschaurek
J. Braun
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S15 - S15
Interstitial radiotherapie of prostate carcinomas with 125-iodine seeds
H. Knüfermann
M. Wannenmacher
H. Sommerkamp
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S15 - S15
Treatment of unresectable carcinoma of pancreas by iodine-125 brachytherapy and external radiation therapy
M. H. Shiu
B. S. Hilaris
M. F. Brennan
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S16 - S16
Induction of leukemias—Indicator of total body irradiation
H. J. Seidel
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S16 - S16
Lung cancer after irradiation: The Radon-problem
W. Jacobi
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S16 - S16
Induction of osteosarcoma after radiation
W. Gössner
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S16 - S16
The German thorotrast study
G. van Kaick
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S17 - S17
Assessment of the total risk of radiation induced tumors at low doses
A. M. Kellerer
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S17 - S17
Quality assurance in cooperative therapy studies (under radiotherapeutical aspects)
R. Sauer
J. Dunst
H. J. Thiel
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S17 - S17
Cisplatin, a sensitizer of hypoxic mammalian cells?
W. Ziegler
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S17 - S17
In vitro assay of radioresponse of human tumors
W. Hinkelbein
M. Berg
H. H. Fiebig
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S18 - S18
Combination of interstitial hyperthermie with high dose rate afterloading radiation therapy
P. Kneschaurek
G. Ries
A. Breit
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S18 - S18
Experiences with afterloading—as intracavital radiotherapy—of non-gynecologic tumors
U. Freund
M. Wannenmacher
G. Bruggmoser
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S18 - S18
Palliation of pain from bone metastases using multiple daily fractions of radiation
G. J. Steiger
J. H. Karstens
J. Ammon
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S18 - S18
Symptomatic radiotherapy of bone metastases
H. J. Tkocz
K. Schnabel
B. Scharding
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S19 - S19
Secondary malignancies after radiotherapy: A retrospective analysis of 454 cases
R. Fietkau
L. Stehr
R. Sauer
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S19 - S19
Treatment of soloid tumors and acute leukemias with the polyamine antimetabolites difluoromethylornithine and methylglyoxal bis (guanylhydrazone)
M. Garbrecht
S. Busch
G. Ziemer
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S19 - S19
Decreased cardiotoxicity of adriamycin by verapamil
U. Millerleile
M. Garbrecht
D. K. Hossfeld
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S19 - S19
Detection, separation and extraction of doxorubicin, 4′-epi-doxorubicin and seven metabolites from plasma samples
K. Mross
P. Maessen
H. M. Pinedo
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S20 - S20
In vitro and phase I clinical studies with 7-con-O-methylnogaril (menogaril)
A. -R. Hanauske
F. A. Dorr
D. L. Kisner
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S20 - S20
Chemistry of new derivatives of 4-hydroxycyclophosphamide
U. Niemeyer
J. Engel
M. Przybylski
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S20 - S20
Phase-I-trial of tumor-necrosis-factor in patients with malignant disease
M. Pfreundschuh
T. Steinmetz
V. Diehl
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S20 - S20
Influence of mesna on the toxicity and therapeutic efficacy of cisplatin
T. Wagner
G. Bohlmann
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S21 - S21
Chemosensitization by cyclosporine A. A new strategy in drug development
R. Osieka
Kloke O.
Schmidt C. G.
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S21 - S21
Metabolism of ether lipids in leukaemic cells
E. A. M. Fleer
D. -J. Kim
H. Eibl
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S21 - S21
(Ether)-Phospholipids in liposomes: The influence of surface charge on organ distribution
P. Kaufmann-Kolle
C. Unger
H. Eibl
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S21 - S21
Anticancer activity of new alkyllysophospholipid-derivates
C. Muschiol
M. R. Berger
H. J. Eibl
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S22 - S22
New drugs in tumour therapy: 1-alkyl-propandiol (1.2) phosphocholines
C. Unger
D. -J. Kim
H. Eibl
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S22 - S22
(Alkyl)-lysophospholipids in tumour therapy: A new concept
H. Eibl
C. Unger
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S22 - S22
Metabolites of 5-fluorouracil in human plasma and urine as determined by¹⁹F-NMR-spektroskopie
R. E. Port
W. E. Hull
W. Kunz
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S22 - S22
Overadditive toxicity of combinations of methylating agents with 2-chloroethylnitrosoureas
W. J. Zeller
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S23 - S23
Evaluation of a soft-agar colony forming assay in gynecologic, tumors and breast cancer
G. E. Umbach
J. Poethen
U. Koldovsky
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S23 - S23
Specific alterations of protein patterns in adriamycin-resistant sarcoma 180 cells
A. Günther
J. Sonka
M. Volm
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S23 - S23
Effects of the synthetic alkyl-lysophospholipid BM 41 440 on clonogeneity of human tumor cells from various histological types
H. A. Neumann
H. M. Runge
R. Engelhardt
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S23 - S23
Effect of the synthetic alkyl-lysophospholipid BM 41 440 on gynaecological tumors
H. M. Runge
H. A. Neumann
W. Kleine
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S24 - S24
The first spectrophotometric assay for determination of O-alkyl cleavage enzymes
J. Kötting
C. Unger
H. Eibl
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S24 - S24
Alkylphosphocholines as Anticancer Agents
M. R. Berger
D. Schmähl
H. J. Eibl
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S24 - S24
Hexadecylphosphocholine, a new Antineoplastic Agent: Cytotoxic properties in leukaemic cells
H. Eibl
C. Unger
G. A. Nagel
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S24 - S24
Antitumour properties of various (alkyl)-lysophospholipid analogues in raji leukaemic cells
D. -J. Kim
C. Unger
H. Eibl
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S25 - S25
Topical application of ether lipids in the treatment of skin metastases
C. Unger
H. Eibl
G. A. Nagel
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S25 - S25
Pharmacokinetics of etoposide in adult patients with cancer
K. H. Pflüger
M. Merkel
K. Havemann
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S25 - S25
Pharmacokinetics of therubicin
A. A. Miller
C. G. Schmidt
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society Mach 4–8, 1996 Munich, Federal Republic of Germany 01 February 1986 Pages: S25 - S25

Volume 111, Issue 1 supplement

Search

Navigation